)
Fennec Pharmaceuticals (FENC) investor relations material
Fennec Pharmaceuticals AGM 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Opening remarks and agenda
Meeting called to order, formal legal business addressed, and agenda outlined, including business updates and Q&A session.
Notice of meeting and proxy materials delivered to shareholders as required.
Quorum confirmed and meeting declared properly constituted for business transactions.
Financial performance review
Record net product sales achieved in 2025, with significant growth in the Fennec HEARS patient support program.
Strengthened financial position through a $42 million equity offering and full debt redemption.
Q1 2026 net product sales reached $15.1 million, up 73% year-over-year from Q1 2025.
Six consecutive quarters of strong performance, with record patient enrollments and highest demand month in April 2026.
Board and executive committee updates
Five directors nominated and elected: Khalid Islam, Chris Rallis, Marco Brughera, Jodi Cook, and Jeff Hackman.
- PEDMARK's expansion and global partnerships drive record growth and long-term market potential.FENC
H.C. Wainwright 4th Annual BioConnect Investor Conference19 May 2026 - PEDMARK® delivers proven protection against cisplatin-induced hearing loss, driving global growth.FENC
Corporate presentation19 May 2026 - Q1 2026 revenues surged 73% to $15.1M, with net income of $201K and U.S. exclusivity secured.FENC
Q1 202614 May 2026 - Virtual meeting to vote on directors, auditors, compensation, and equity plan amendments.FENC
Proxy filing28 Apr 2026 - PEDMARK® delivers proven protection against cisplatin-induced hearing loss, driving growth and global expansion.FENC
Corporate presentation28 Apr 2026 - Record sales, AYA growth, and U.S. exclusivity set the stage for strong 2026 expansion.FENC
Q4 202524 Mar 2026 - Q2 2024 sales doubled to $7.3M, fueled by PEDMARK growth and a $43.2M Norgine deal.FENC
Q2 20241 Feb 2026 - Pedmark is the sole approved therapy for pediatric cisplatin hearing loss, with global expansion underway.FENC
H.C. Wainwright 26th Annual Global Investment Conference 202420 Jan 2026 - Q3 sales rose to $7M, AYA adoption strong, cash funds operations into 2026.FENC
Q3 202416 Jan 2026
Next Fennec Pharmaceuticals earnings date
Next Fennec Pharmaceuticals earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage